Clinical Trial Update: The Effects of Peroxisome Proliferators Activated Receptor-Gamma (PPAR-γ) Agonists on Certain Biochemical and Inflammatory Markers in Metabolic Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of PPAR-γ agonists on biochemical and inflammatory markers in metabolic syndrome; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• PPAR-γ agonist class (peroxisome proliferator-activated receptor gamma agonist)

Snippet

Sponsor: Aligarh Muslim University | Conditions: Metabolic Syndrome | Phase 4 | Status: COMPLETED